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Abstract.  SPARC (osteonectin/BM40) is a secreted 
protein that modifies the interaction of ceils with ex- 
tracellular matrix (ECM).  When we added SPARC to 
cultured rabbit synovial fibroblasts  and analyzed the 
secreted proteins, we observed an increase in the ex- 
pression of three metalloproteinases-collagenase, 
stromelysin, and the 92-kD gelatinase-that together 
can degrade both interstitial and basement membrane 
matrices. We further characterized the regulation of 
one of these metalloproteinases, collagenase, and 
showed that both collagenase mRNA and protein are 
upregulated in fibroblasts treated with SPARC. Experi- 
ments with synthetic SPARC peptides indicated that a 
region in the neutral or-helical domain III of the 
SPARC molecule, which previously had no described 
function, was involved  in the regulation of collagenase 
expression by SPARC. A sequence in the carboxyl- 
terminal CaE+-binding domain IV exhibited similar ac- 
tivity, but to a lesser extent. SPARC induced col- 
lagenase expression in cells plated on collagen types I, 
II, III, and V, and on vitronectin, but not on collagen 
type IV.  SPARC also increased collagenase expression 
in fibroblasts plated on ECM produced by smooth 
muscle cells, but not in fibroblasts plated on a base- 
ment membrane-like ECM from Engelbreth-Holm- 
Swarm sarcoma. Collagenase was induced within 4 h 
in cells treated with phorbol diesters or plated on 
fibronectin fragments, but was induced after 8 h in 
cells treated with SPARC. A number of proteins were 
transiently secreted by SPARC-treated  cells within 6 h 
of treatment. Conditioned medium that was harvested 
from cultures 7 h after the addition of SPARC, and 
depleted of residual SPARC, induced collagenase ex- 
pression in untreated fibroblasts; thus, part of the 
regulation of collagenase expression by SPARC ap- 
pears to be indirect and proceeds through a secreted 
intermediate. Because the interactions of cells with 
ECM play an important role in regulation of cell be- 
havior and tissue morphogenesis, these results suggest 
that molecules like SPARC are important in modulat- 
ing tissue remodeling and cell-ECM interactions. 
T 
hE interactions  of a cell with its surrounding extra- 
cellular matrix (ECM) ~  can play an important role in 
the regulation of cell behavior and tissue architecture. 
While most cells in adult tissues remain anchored in place 
through specific interactions with tissue matrices, subsets of 
differentiated  cells  are  specialized  to  move  through  the 
ECM. Biological cues can also induce normally stationary, 
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adherent cells to move over and through the ECM. In some 
cases, a specific interaction  of a cell with certain matrices 
can help to stabilize or maintain a phenotype or particular 
tissue structure (Menko and Boettiger, 1987; Sorokin et al., 
1990; Adams and Watt, 1990); in actively remodeling tis- 
sues, however, the cellular interaction with ECM is not static 
but is constantly  changing  (Mackie et al.,  1988; ffrench- 
Constant et al., 1989; Gladson and Cheresh,  1991; Damsky 
et ai.,  1992). 
Diversity in celI-ECM interactions is the consequence of 
several factors: the integration of the transcriptional regula- 
tion of ECM components and their receptors,  the net ac- 
cumulation of ECM constituents resulting from the balance 
of synthesis and degradation of ECM molecules, and the as- 
sembly of  the ECM components into tissue-specific matrices 
(Cheresh et al., 1989; Dahl and Grabel,  1989; Dustin and 
Springer,  1991; for review see Hay, 1991; Damsky et al., 
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preted by cells in the decision to adhere, invade, migrate, se- 
crete, or differentiate. There is strong correlative evidence 
that information transduced into the cell by adhesion of cells 
to specific matrices can lead to alterations in cell phenotype 
or  to  changes in gene expression (Menko and Boettiger, 
1987; Werb et al.,  1989;  Sorokin et al.,  1990;  Adams and 
Watt, 1990; Talhouk et al., 1992; for review see Burridge et 
al.,  1988;  Hynes, 1992).  Apart from establishing adhesive 
contacts with the ECM, a cell must somehow modify these 
contacts with the matrix, i.e., to de-adhere or break the in- 
teraction with the matrix. Controlled proteolysis might be 
one mechanism used by cells to diminish adhesive contacts 
with the ECM. Proteinases have been shown to be present 
at focal contacts in certain cells and can act to modulate the 
assembly of the actin cytoskeleton in these cells (Beckerle 
et al., 1987; Estreicher et al., 1990). ECM-degrading metal- 
loproteinases are specifically enhanced in fibroblasts plated 
on fragments of fibronectin when compared with fibronectin 
or collagen type I (Werb et al., 1989), a response that could 
also diminish adhesion of cells to the ECM. Another way to 
effect changes in cell adhesion is to modify existing matrices 
by deposition or synthesis of additional matrix-associated 
molecules.  Several  ECM-associated molecules,  including 
SPARC,  thrombospondin, dermatan sulfate proteoglycans, 
and tenascin, have been shown to perturb the adhesion of 
cells to the matrix (Sage et al.,  1989c; Lawler et al., 1988; 
Murphy-Ullrich  and  Hook,  1989;  Chiquet-Ehrismann, 
1991;  Murphy-Ullrich et al.,  1991). Thrombospondin and 
tenascin have both adhesive and anti-adhesive properties, 
and may interact with cells in a way that Arg-Gly-Asp (RGD) 
inhibits (Lawler et al., 1988; Bourdon and Ruoslahti, 1989), 
whereas SPARC acts in a manner insensitive to RGD (Sage 
et al.,  1989c). 
SPARC, tenascin, and thrombospondin are expressed tran- 
siently in tissues that are actively remodeling their matrix, 
where  cells  are  dividing  or  migrating  (for  review  see 
Chiquet-Ehrismann, 1991; Sage and Bornstein, 1991). Al- 
though SPARC is expressed transiently in a wide range of  tis- 
sues  during  development,  in  adults  SPARC  is  expressed 
chiefly in rapidly renewing populations of cells (Sage et al., 
1989a,b). MetaUoproteinase expression is also increased in 
regions of tissue where increased cell division, migration, or 
remodeling is observed (for review see Alexander and Werb, 
1991).  This  is  interesting  because  the  expression  of the 
ECM-degrading  metalloproteinases collagenase and  stro- 
melysin correlates with perturbation of the actin cytoskel- 
eton (Unemori and Werb, 1986), and tenascin, SPARC, and 
thrombospondin in culture have been shown to destabilize 
actin in focal contacts (Murphy-Ullrich et al.,  1991). 
The expression of collagenase and stromelysin is induced 
in  cultured  rabbit  synovial  fibroblasts  (RSF)  plated  on 
fibronectin fragments or on anti-fibronectin receptor anti- 
body but not on substrates of  intact plasma fibronectin (Werb 
et al., 1989).  This culture system might therefore be useful 
in the dissection of information transduced by celI-ECM in- 
teractions. Because SPARC diminishes adhesion of cultured 
cells  by destabilizing focal contacts (Sage et al.,  1989c; 
Murphy-Ullrich et al.,  1991), we designed experiments to 
determine whether the addition of SPARC to cultured syno- 
vial fibroblasts alters the expression of metalloproteinases in 
these cells. 
Materials and Methods 
Cells and Cell Culture 
RSE isolated as described previously (Aggeler et al.,  1984a,b) and used 
between passages 1 and 10, were cultured in DME (Cell Culture Facility, 
University of California,  San Francisco), supplemented with  10%  FBS 
(Hyclone Labs., Logan, UT). Cells (0.5-1  x  105) were plated in uncoated 
24 or 48-well tissue culture dishes (Costar Corp., Cambridge, MA), and 
cultured  in  DME  containing  10%  FBS  for  3-4  h,  afler  which  the 
monolayers were washed and incubated further in DME supplemented with 
0.2%  lactaibumin hydrolysate (LH)  (GIBCO BRL,  Gaithersburg,  MD). 
Cells were plated on ECM-coated dishes at a density of 105 and were cul- 
tured in one of two serum-free media,  DME-LH or Fibroblast Growth 
Medium (Clonetics Corp., San Diego, CA). 
Preparation of  ECM Ligand Substrates 
Fibronectin was purchased from Collaborative Research (Bedford, MA) 
and Boehringer Mannheim Corp. (Indianapolis, IN); fibronectin fragments 
and vitronectin were purchased from Telios Pharmaceuticals (San Diego, 
CA). Bovine collagen type I (Vitrogen) was purchased in a solution of 0.1 N 
HCI from the Collagen Corp. (Palo Alto, CA); collagen types I, II, III, IV, 
V were purchased from Collaborative Research or from Eureka Laborato- 
ries (Sacramento, CA) and reconstituted as directed by the manufacturer. 
Culture dishes were coated with fibronectin or vitronectin at 10-20 #g/ml 
by incubating them overnight (9-15 h) in PBS, pH 7.4, at 4°C. Human colla- 
gen types I, II, III, IV, V, or bovine collagen type I were diluted from acidic 
solutions into distilled water to a  concentration of 20 #g/ml and culture 
dishes were further incubated in this solution overnight (9-15 h) at 4°C. Un- 
occupied binding sites were blocked by incubation with 0.2% BSA (Sigma 
Chem. Co., St. Louis, MO) at ambient temperature for 2 h; wells were then 
washed three times with PBS and used immediately. Culture dishes coated 
with a basement membrane matrix from Engelbreth-Holm-Swarm (EHS) 
sarcoma (Alexander and Werb,  1992) or the smooth muscle matrix from 
R22 rat smooth muscle cells (Werb et al., 1980) were prepared as described 
previously. 
Addition of  SPARC or SPARC Peptides to 
Cell Cultures 
SPARC was prepared from mouse parietal yolk sac (PYS-2) cells as de- 
scribed previously (Sage et al., 1989c).  Purified SPARC was solubilized in 
PBS at a concentration of 250 #g/ml and used at a final concentration of 
10-40 #g/ml;  SPARC  was used as a  soluble ligand except where noted 
otherwise. In many experiments we used a slightly less pure (90%) fraction 
of SPARC (DESPARC), isolated by anion-exchange  chromatography, which 
contains a carder protein for SPARC; this protein was more stable and avail- 
able in larger quantities than pure SPARC.  The synthetic peptides used in 
this study were synthesized, characterized, and used as described previ- 
ously (Lane and Sage,  1990). 
Antibodies 
The mouse anti-rabbit collagenasc mAbs used for immunoprecipitations 
and analysis of secreted collagenase in this study were described by Werb 
et al. (1989).  The mouse anti-human stromelysin antibody, SL188.2  (Wil- 
helm et al., 1992) used in the immunoblots was a generous girl of Dr. Scott 
Wilhelm (Miles  Research,  West Haven,  CT).  The  horseradish peroxi- 
dase-conjugated and  biotinylated  secondary antibodies were purchased 
from Sigma Chem. Co.  Texas  red-streptavidin conjugate was purchased 
from Amersham Corp. (Arlington Heights, IL). Goat anti-SPARC antibody 
was prepared with purified SPARC as antigen, and its specificity character- 
ized by immunoprecipitation and immunoblotting; the titer was measured 
by ELISA, and was maximal at  1:500  and half-maximal at  1:250. 
To deplete SPARC from the medium, we incubated 500 #1 of antiserum 
or normal goat serum with 100 #1 packed protein G-Sepharose beads (Phar- 
macia LKB Biotechnology Inc., Piscataway,  N J) for 1 h and washed them 
extensively with PBS, and then incubated the beads with 200 #1 conditioned 
medium (CM) for 1 h. 
Biosynthetic Labeling of  Secreted Proteins and 
Analysis of  Metalloproteinases 
Proteins were biosynthetically labeled by incubating cultures with 50-100 
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MA) for 2-4 h in methionine-free  DME at 37°C. Secreted proteins were 
precipitated  from the CM with quinine sulfate and SDS as described (Un- 
emori and Werb, 1986). Samples were then analyzed by SDS-PAGE using 
the Laemmli buffering system followed by fluorography (En3Hance, New 
England Nuclear),  as previously described (Unemori and Werb, 1986). Al- 
ternatively,  eollaganase  in the radiolabeled  CM was immunoprecipitated 
with a mixture of anti-collagenase mAbs (Werb et al., 1989). Zymography 
was used to analyze the gelatinases in the CM (3Verb et ai.,  1989). The 
stromelysin  and collagenase protein  in the enriched  culture  supernatants 
was also identified by immunnblotting procedures (Harlow and Lane, 1988) 
with the use of anti-human  stromelysin mAb (Wilhelm et al., 1992) and 
anti-rabbit  eollagenase  mAbs  (Werb  et al.,  1989). Briefly the CM was 
resolved by SDS-PAGE and the proteins were transferred to Immobilon P 
membranes (New England Nuclear). Unoccupied binding sites on the mem- 
brane  were blocked by incubation with 3% BSA in TBS (150 mM NaC1, 
20 mM Tris-HC1, pH 7.5), washed once with TBS, and incubated with the 
primary  antibody for 1-2 h. The membrane was washed briefly with TBS, 
and then washed three times for 20 min with a solution of TBS containing 
0.5% Tween-20 (Sigma Chem. Co.).  After incubation with a horseradish 
peroxidase-conjugated  secondary anti-mouse antibody, the membrane was 
washed as described above, and specific bands were visualized by enhanced 
chemiluminescence  (Amersham Corp.)  as described by the manufacturer. 
To quantify the amount of collageuase in the CM, we applied dilutions of 
the CM to nitrocellulose membranes (Schleicher and Schuell, Inc., Keene, 
NH) using a slot-blot filtration manifold (Schleicher and Schuell, Inc.). The 
filters were blocked and incubated with anti-collagenase antibodies as de- 
scribed above. The resulting films were scanned by laser densitometry and 
the amounts of collngenase in the CM were compared. 
RNA Isolation, Polymerase Chain Reaction, 
Hybridization Conditions, and cDNA Probes 
Total cellular RNA was isolated from cultured cells and 1-#g samples were 
analyzed  by reverse transcription  (RT) and  amplification  of specific se- 
quences by the PCR (Rappolee et al., 1989). Synthetic primers used to am- 
plify eollagenase eDNA sequences were selected from regions of identity 
in the rabbit  and human eDNA sequences.  The eollagenase primer pair 
(nncleotides  1154-1174 and  1433-1453  in  the  rabbit  collagenase  gene 
[Brenner  et al.,  1989]) amplified a  300-bp  fragment  of the transcribed 
cDNA. Synthetic primers used to amplify eDNA sequences coding for the 
housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 
spanned the sequence 3308-3337  and 3649-3672  in the rat gene, and pro- 
duced a 241-bp fragment (Rappolee et al., 1989). Amplifications with both 
primer pairs were performed with 4 mM MgC12 at an annealing tempera- 
rare of 60°C. 
PCR products were analyzed by agarose gel electrophoresis followed by 
staining with ethidium bromide. For quantification of  the amplified product, 
negatives of the gels were analyzed by scanning densitometry, and the area 
under the peak corresponding to specific bands was plotted against the dilu- 
tion of the RT mixture used in that amplification. The amounts of GAPDH 
and collagenase mRNA in the RT mixture were compared in the linear por- 
tion of  the curve. To analyze mRNA by blotting, we applied a series of linear 
dilutions of total RNA to nylon membranes using a slot-blot filtration mani- 
fold  (Sambrook  et  al.,  1989). The  filter  was  probed  with  32p-labeled 
eDNA inserts from pCL1, a clone of rabbit coUagenase  (Frisch et al., 1987), 
and human 3'-actin (Engel et ai., 1981; a gift ofL. Kedes, Stanford Univer- 
sity, Palo Alto,  CA) as described  (Werb et ai.,  1989). 
Results 
The Expression of  Metailoproteinases Is Upregulated 
in Synovlal  Fibroblasts Treated with SPARC 
To determine if SPARC alters expression of proteins synthe- 
sized by RSF,  we added purified  SPARC or DESPARC  to 
adherent  RSF in culture.  We compared the expression of 
proteins  secreted  by SPARC-treated cells with that of pro- 
reins  secreted  by  untreated cells.  We  also incubated  cells 
with  the  phorbol  diester  12-O-tetradecanoylphorbol-13- 
acetate  (TPA),  which  rapidly  induces  the  expression  of 
metalloproteinases  in  many  cell  types  (Frisch  and Werb, 
Figure 1. SPARC induces the synthesis and secretion of proteins in 
synovial  fibroblasts.  Freshly  trypsinized  RSF  were  cultured  in 
DME-10% FBS in 48-well plates for 3 h. The cells were incubated 
further in DME-LH (L/-/, lanes 1 and 2, in duplicate) or DME-LH 
supplemented with either 100 ng/ml TPA (lanes 3 and 4, in dupli- 
cate), 30 #g/ml pure SPARC (lanes 5 and 6, in duplicate), 15 #g/ml 
pure SPARC (lanes 7 and 8, in duplicate), or 30 #g/ml DESPARC 
(lanes 9 and 10, in duplicate) for 30 h. The CM was removed, and 
the proteins  were biosynthetically labeled by  incubation  of cells 
with [35Slmethionine in methionine-free DME for 2 h. The radio- 
labeled secreted proteins were concentrated with quinine sulfate- 
SDS  and  analyzed  by  SDS-PAGE and  autoradiography.  Procol- 
lagenase (CL), migrating at 53 and 57 kD, is indicated on the right. 
Molecular weight (x  10  -3)  markers  are indicated on the left. 
1989).  SPARC induced the synthesis of biosynthetically  la- 
beled secreted proteins migrating between 50 and 60 kD that 
are characteristic  of  the proenzyme forms of collagenase and 
stromelysin (Fig. 1). We detected no difference in the pattern 
of metalloproteinase  expression in  RSF  induced  by pure 
SPARC and DESPARC,  and,  unless otherwise stated,  the 
two were used interchangeably  in later experiments. 
To identify and quantify the metalloproteinases  in the CM 
harvested from SPARC-treated RSF, we used mAbs against 
collagenase  and stromelysin.  Immunoprecipitable collage- 
nase represented >30% of the radiolabeled protein secreted 
by RSF after treatment with SPARC for 40 h (Fig. 2 A). In- 
creases in total collagenase  and  stromelysin  were also de- 
tected  by  immunoblotting  CM  harvested  from  SPARC- 
treated RSF (Fig. 2 B). Changes in proteolytic activity were 
evident on zymograms that used a gelatin substrate incorpo- 
rated into the resolving gel.  Increases in the gelatinolytic 
doublet of collagenase, migrating at 57 and 53 kD, and of the 
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expression of  collagenase pro- 
tein  in  synovial  fibroblasts. 
(A)  Freshly  trypsinized  RSF 
plated in 48-well plates  were 
allowed to attach  and  spread 
in  DME-10% FBS  for 3  h. 
The  medium  was  removed, 
the monolayers were  washed 
and cells were incubated fur- 
ther in DME-LH or in DME- 
LH supplemented with 30/zg/ 
ml  DESPARC  for  40  h. 
The  CM  was  removed  and 
saved for later  analysis.  The 
proteins were biosynthetically 
labeled  for  3  h  by  incuba- 
tion of cells with 50 #Ci/ml of 
[35S]methionine  in  methio- 
nine-free  DME.  Samples  of 
CM containing radiolabeled secreted proteins from untreated RSF (LH, lanes 1 and 3) or RSF treated with DESPARC (SPARC, lanes 2 
and 4) were concentrated with quinine sulfate-SDS (lanes 1 and 2) to show total proteins secreted into the medium, or proteins secreted 
into the medium were immunoprecipitated  with anti-collagenase mAbs (lanes 3 and 4) and the precipitates  were separated on a  10% 
SDS-polyacrylamide gel and analyzed by autoradiography. The doublet of procollagenase (CL) is indicated by arrows. (B) CM harvested 
from untreated RSF (LH, lanes 1 and 3) or SPARC-treated RSF (SPARC, lanes 2 and 4) was separated on a  10% SDS-polyacrylamide 
gel under denaturing conditions, and the proteins were transferred to membranes and analyzed by immunoblotting with anti-collagenase 
mAbs (lanes 1 and 2) or an anti-stromelysin mAb (lanes 3 and 4). Procollagenase (CL) and prostromelysin (SL) are indicated by arrows. 
(C) The proteinase content of the 40-h CM harvested from untreated RSF or from RSF treated with SPARC was analyzed by zymography. 
The proteins were separated on a 10% polyacrylamide gel that contained 0.1% gelatin under nondenaturing conditions. The zymograms 
were stained with Coomassie blue R250 after development overnight (14 h).  Proteolytic degradation of gelatin appears as a clear band 
on a dark background.  Note the induction of gelatinases migrating at 92,  57, and 53 kD corresponding  to the proenzyme forms of the 
92-kD gelatinase (92) and collagenase (CL). Molecular  weight (xl0  -3) markers are indicated on the left. 
92-kD gelatinase show that these metalloproteinases are in- 
duced by SPARC (Fig. 2  C). In the rest of the experiments 
described in this report,  we concentrated on the effects of 
SPARC on the regulation of coUagenase gene expression. 
Regardless  of the  basal  level  of coUagenase  secretion, 
SPARC  reproducibly  upregulated  the  expression  of  col- 
lagenase in RSE The induction of collagenase in RSF treated 
with SPARC, measured as radiolabeled secreted collagenase 
protein,  was quantified by scanning densitometry of auto- 
radiographs (Table I). There was a mean 5.3-fold increase (+ 
2.7 SD) in the expression of collagenase in cultures treated 
with SPARC, compared with untreated cultures (n  =  8 ex- 
periments, 2-3 replicates per treatment, p  <  0.01; Student's 
t test). By comparison TPA induced an 8.6-fold increase (+ 
1.8 SD) in collagenase expression. Induction of collagenase 
expression  in  RSF  was  found using  three preparations  of 
SPARC and in RSF strains derived from six rabbits. 
In the preceding experiments we examined the effect of 
SPARC on the amounts of collagenase protein secreted by 
RSE  We used RT-PCR to analyze the effect of SPARC on 
mRNA  for collagenase.  The  accumulation  of collagenase 
mRNA increased fivefold in RSF treated with SPARC (Table 
I), and when normalized for mRNA for the housekeeping 
gene GAPDH (Fig. 3), this increase correlated with the ex- 
pression of collagenase protein by RSF treated with SPARC. 
The data analyzed in Fig. 3 B are an average of three experi- 
ments. In a separate blotting analysis of RNA from one ex- 
periment, a  series of sequential dilutions of RNA was ap- 
plied to nylon membranes with a filtration manifold, and the 
membrane was probed with  32p-labeled  eDNA probes for 
collagenase and 3,-actin.  The autoradiographs were scanned 
and, normalizing to the level of 3,-actin  expression, we saw 
a threefold increase in collagenase mRNA in cultures treated 
with SPARC compared with untreated control cultures; this 
increase was comparable to the levels obtained with RT-PCR 
(data not shown). 
Previous studies have indicated that induction of collage- 
nase  and  stromelysin gene  expression  strongly  correlates 
with cell rounding, although treatment of RSF with a func- 
Table L  Collagenase Expression in RSF Treated with 
SPARC and SPARC Peptides 
Peptide*  Collagenase induction  Go/S delay~  t  Shape change§ 
(-fold) 
SPARC  5.3  +  2.711  Yes  Yes 
1.1  1.2  +  0.4  No  Yes 
2.1  1.1  +  0.  Yes  No 
3.2  10.0  +  1.711  No  No 
3.4  1.1  -t-  0.511  No  No 
4.2  4.3  +  0.511  No  Yes 
TPA  8.6  d-  1.811  ND  Yes 
To facilitate comparison of results from five experiments,  we expressed data 
as "-fold induction" by normalizing data from treated to untreated cultures in 
individual experiments.  For SPARC,  eight different experiments  were aver- 
aged.  Data are shown as mean  :[:  SD. 
* See Fig. 6 A for location of peptides in the SPARC molecule. Peptides had 
the same structure as that described by Lane and Sage (1990) and were added 
to RSF at 0.8  mM for 30 h.  SPARC was added at 30 tLg/ml. 
:~ From Funk and Sage (1991). 
§ From Lane and Sage (1990). 
II Significantly different from untreated  controls  (p <  0.05,  Kruskall  Wallis 
test). 
ND,  Not done. 
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regulated  by SPARC. Freshly trypsinized RSF were 
cultured on type I collagen-coated wells in DME-LH 
or in DME-LH containing 30 #g/ml SPARC for 30 h. 
The total cellular RNA was isolated and analyzed by 
RT-PCR. (A) Sequences in eDNA were amplified with 
the use of specific primers for collagenase eDNA and 
GAPDH eDNA to yield 300- and 241-bp fragments, 
respectively.  The products were separated  on agarose 
gels  and  stained  with  ethidium  bromide.  For am- 
plification of the collagenase  (CL) mRNA, the eDNA 
derived by RT of 2 #g RNA from control (COL) and 
SPARC-treated  RSF (COL + SPARC)  was diluted  to 
10  -2 (lanes 2 and 8),  5  x  10  -2 (lanes 3 and 9),  10  -3 
(lanes  4  and  It)),  5  x  10  -3 (lanes  5  and  I/),  10  -4 
(lanes  6 and 12), or 5  x  10  -4 (lanes  7 and 13). For 
amplification  of GAPDH mRNA, the eDNA derived 
by RT of 2  #g RNA from untreated RSF and RSF 
plated  on  collagen  and  treated  with  SPARC  was 
diluted to 10  -1 (lanes 2 and 8), 5  x  10  -1 (lanes 3 and 
9),  10  -2 (lanes 4 and 10), 5  x  10  -2 (lanes 5 and 1/), 
10  -3 (lanes 6and 12), and 5  x  10  -3 (lanes  7and 13); 
lane I contained no template.  (B) The data from three 
independent  experiments  were  quantified  by  den- 
sitometry and are expressed as -fold induction (the ra- 
tio of values  from SPARC-treated  to untreated RSF 
values).  Shaded bars represent  mean values from un- 
treated ceils plated on collagen, and open bars repre- 
sent values from cells plated  on collagen and treated 
with SPARC. Lines at the end of bars indicate  SD. 
tion-perturbing anti-fibronectin receptor antibody can induce 
collagenase without significant change in cell shape (Aggeler 
et al.,  1984b; Werb et al.,  1989). As in the regulation of col- 
lagenase in cells plated on fibronectin fragments or treated 
with anti-fibronectin receptor antibody, SPARC induced col- 
lagenase expression without a major morphological change 
(Fig.  4).  This  contrasts  with  the  marked  rounding  of en- 
dothelial  cells  and  nuchal  fibroblasts  treated  with  SPARC 
(Sage et al.,  1989c). 
The Induction of Collagenase by SPARC Is 
ECM-Specific 
Because SPARC expression is tightly regulated during devel- 
opment and tissue remodeling,  we wished to determine  if 
there are particular ECM contexts in which SPARC initiates 
a  remodeling  cascade involving metalloproteinase  expres- 
sion. Accordingly, we plated fibroblasts in serum-free medi- 
um in wells that had been coated with collagen types I, II, 
11I, IV, or V, with vitronectin, or with the more complex ma- 
trices synthesized by EHS tumor cells and R22 smooth mus- 
cle cells. 
SPARC increased collagenase synthesis 2-3-fold in RSF 
that were plated on vitronectin or collagens of types I, 1I, HI, 
and V, but not in cells plated on collagen type IV (Fig.  5). 
SPARC was an inductive ligand for cells plated on R22 ma- 
Figure 4. SPARC induces collagenase without inducing cell round- 
ing in RSE Freshly trypsinized RSF were cultured on glass cover- 
slips in DME-10%  FBS for 3 h. The cells were incubated in DME- 
LH  (A  and  B)  or  in  DME-LH  supplemented  with  30  /zg/ml 
DESPARC  (C and D)  for 30 h, then fixed,  permeabilized,  and 
stained  with anti-collagenase  mAbs. Paired phase-contrast (A and 
C) and immunofluorescent  micrographs (B and D) are shown. Bar, 
10 #m. 
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Figure 5. SPARC induces collagenase expression in matrix-specific 
fashion.  RSF were plated in 48-well plates that were coated with 
ECM  proteins-collagens  (COL) of types  I,  II,  III,  IV,  or  V; 
vitronectin (VN), EHS matrix, R22 matrix-in Fibroblast Growth 
Medium alone or with 30/~g/ml DESPARC (SPARC)  and incubated 
for 30 h. The proteins were biosynthetically labeled by incubating 
cells  with  [35S]methionine,  and the labeled secreted collagenase 
was quantified by scanning densitometry after SDS-PAGE and au- 
toradiography. Open bars indicate coUagenase synthesized by un- 
treated RSF plated on the indicated matrix molecule. Shaded bars 
indicate total collagenase secreted into the culture medium from 
RSF plated on the indicated matrix molecule and treated with 30 
#g/ml SPARC. Means of duplicate samples are shown; lines at end 
of bars indicate range. 
trix  (which  consists  predominantly  of elastin and  collagen 
types I and HI), but not for cells plated on EHS matrix (pre- 
dominantly laminin,  collagen  type IV, and heparan  sulfate 
proteoglycan)  (Fig.  5).  Because the basal  secretion of col- 
lagenase on EHS matrix was no lower than it was on other 
matrices in this experiment, and because cells plated on an- 
other basement membrane component  (pure collagen  type 
IV) did not regulate collagenase in response to SPARC, it is 
unlikely that TGF-/3, which is known to be associated with 
some preparations  of EHS  matrix,  abrogated  the  effect of 
SPARC in lhese experiments. These results indicate that ceils 
treated with SPARC synthesize more collagenase than do un- 
treated  fibroblasts plated on the matrices. 
SPARC Peptides Also Induce CoUagenase Expression 
Sequence  analysis has  indicated that there are four unique 
structural  domains  in  the  SPARC  molecule (Mason  et al., 
1986;  Engel  et  al.,  1987):  I,  an  acidic  Ca2+-binding  do- 
main; H, a cysteine-rich domain; HI, a neutral a-helical se- 
quence containing a serine proteinase-sensitive site; and IV, 
a high-affinity Ca2+-binding EF handlike  structure (Fig.  6). 
One approach that has been used successfully to define the 
structural  motifs  of the  SPARC  molecule  that  affect  cell 
Figure  6.  SPARC  peptides 
from domains HI and IV regu- 
late  collagenase  expression. 
(A) Schematic diagram of the 
SPARC molecule showing the 
location  of specific  domains 
and the synthetic peptides (1.1, 
2.1, 3.2, 3.4, and 4.2) used in 
this  study.  (B) The synthetic 
peptides (0.8 mM or 0.08 mM) 
or 30/~g/ml DESPARC were 
added  to  RSF  plated  in  48- 
well  plates.  Cultures  were 
incubated for 24 h,  and then 
radiolabeled with  pS]methi- 
onine for 2 h. Biosynthetically 
labeled secreted proteins were 
analyzed  by  SDS-PAGE  and 
autoradiography.  This  panel 
shows  the  induction  of col- 
lagenase  in  RSF  incubated 
with  DME-LH  alone  (LH, 
lanes 1, 2,  17,  and  18),  with 
100  ng/ml TPA (lanes 3  and 
4),  with  DESPARC  (lanes 5 
and 6), or with synthetic pep- 
tide 4.2 (0.8 raM) (lanes 7and 
8),  peptide  3.2  (0.8  mM) 
(lanes 9 and 10), peptide  1.1 
(0.8 raM)  (lanes 11  and 12), 
peptide 4.2 (0.08 mM) (lanes 
13  and  14), or  peptide  3.2 
(0.08 mM) (lanes 15 and 16). 
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lagenase  expression  in  RSF 
with  slower kinetics  than  is 
seen  for  TPA  or  fibronec- 
tin  fragments.  Freshly  tryp- 
sinized  RSF  were  plated  in 
wells  coated  with  collagen 
type  I  in  DME-LH  alone 
(COL), or in DME-LH  sup- 
plemented  with  30  #g/ml 
SPARC  (COL SPARC),  or 
with  100  ng/ml TPA  (COL 
TPA), or in wells coated with 
fibronectin (FN), or with the 
120-kD  chymotrypsin  frag- 
ment of fibronectin (120  FN). 
The cultures  were  incubated 
for 2--44 h, and proteins were 
biosynthetically labeled by in- 
cubation with  100 #Ci/ml  of 
[35S]methionine for 2 h.  The 
radiolabeled  secreted  colla- 
genase was analyzed by immunoprecipitation with anti-collagenase mAbs, and the precipitates were resolved by electrophoresis on a 10% 
SDS-polyacrylamide gel. (A) Autoradiogram of the immunoprecipitated radiolabeled collagenase protein. (B) Quantification of secreted 
collagenase by densitometry of autoradiographs. 
adhesion (Lane and Sage, 1990) or the cell cycle (Funk and 
Sage,  1991)  is the  synthesis of peptides corresponding to 
regions in domains I-IV and the monitoring of their efficacy 
in mimicking SPARC  function. We tested a  panel of syn- 
thetic peptides spanning portions of each of the four domains 
of the SPARC  molecule (Lane and  Sage,  1990)  to define 
which domains in the SPARC molecule confer regulation of 
metalloproteinases in RSF. 
Peptides in domain I (1.1) and domain IV (4.2) destabilize 
adhesion  of cells  to  the  ECM  and  thus  mimic  the  anti- 
adhesive properties of SPARC. Addition of  peptide 4.2, at 0.8 
mM,  to cultures of adherent RSF induced c011agenase ex- 
pression (Fig. 6, Table I). We detected no significant induc- 
tion of collagenase in response to peptide 1.1 (Fig. 6). Pep- 
tide 2.1, like intact SPARC, delays the Go/S transition when 
added to endothelial cells in culture (Funk and Sage, 1991); 
however, it did not induce collagenase expression in RSF 
(Fig. 6, Table I). Surprisingly, we saw an induction of col- 
lagenase in cells treated with peptide 3.2, which is in the neu- 
tral o~-helical domain III; peptide 3.2 was inductive at 0.08 
mM, which is a tenfold lower concentration than was induc- 
tive with peptide 4.2. Similar results were obtained with two 
different preparations of peptide 3.2.  Peptides representing 
nearby  sequences,  both  amino-terminal  (peptide 2.1)  and 
carboxyl-terminal (peptide 3.4), did not induce collagenase 
expression (Table I). These results suggest that regions in do- 
main  HI  and  IV  in  the  SPARC  molecule  induce  metal- 
loproteinase expression in fibroblasts. 
The Regulation of CoUagenase Expression by 
SPARC Is Temporally Distinct  from Induction by 
TPA or Fibronectin Fragments 
Previous experiments have shown that fibronectin fragments 
and TPA induce collagenase expression within 4  h  (Werb 
et al.,  1989).  To characterize the timing of the induction 
of collagenase by SPARC,  we compared the time course of 
collagenase induction by SPARC,  TPA,  and  fragments of 
fibronectin.  RSF  were  plated  in  serum-free  medium  in 
collagen-coated wells,  some of which were supplemented 
with 30/~g/ml DESPARC or 100 ng/ml TPA, or in wells that 
had been coated with fibronectin or the 120-kD chymotryp- 
sin fragment of fibronectin. At various times (2--44 h) after 
plating we incubated the cultures with [35S]methionine  for 
2 h, immunoprecipitated the radiolabeled secreted collage- 
nase from the CM, and analyzed the immunoprecipitates by 
SDS-PAGE and autoradiography. Collagenase synthesis was 
detected in SPARC-treated cultures after 8 h but was appar- 
ent within 4 h in cultures plated on fibronectin fragments or 
treated with TPA (Fig. 7). When we analyzed the total pro- 
teins secreted by RSF after a 2-6-h incubation with SPARC, 
we noted the transient induction of several proteins that were 
not secreted by RSF treated with TPA (Fig.  8). 
SPARC Induces CoUagenase Expression by an 
Indirect Mechanism 
The data presented in Figs. 6, 7, and 8 suggest at least two 
potential mechanisms by which SPARC  may regulate col- 
lagenase expression in fibroblasts. The slow induction of  col- 
lagenase (>10 h) in RSF treated with SPARC is reminiscent 
of the time course of coUagenase induction in RSF elicited 
by agents that act by shape-dependent mechanisms, such as 
cytochalasins or culture in retracted collagen gels (Unemori 
and Werb, 1986). In our experiments, however, SPARC did 
not appear to alter the morphology of RSF. Alternatively, the 
induction of collagenase in cells treated with SPARC may be 
mediated by one of the molecules induced in SPARC-treated 
cultures before collagenase expression is induced. Although 
the experiment with SPARC peptides also suggests that two 
domains in the SPARC molecule regulate the expression of 
collagenase, possibly by distinct mechanisms, for simplicity 
we decided to clarify the mechanism by which native, intact 
SPARC  affects the expression of collagenase in fibroblasts. 
To determine if the increase in collagenase expression was 
a direct response to treatment of cells with SPARC, or was 
Tremble et al. SPARC  Induces Collagenase  1439 Figure  8.  SPARC treatment 
transiently  induces  the  ex- 
pression  of several novel se- 
creted  proteins.  RSF  were 
plated  in  48-well  plates  in 
DME-10% FBS for 3 h.  The 
medium  was  then  replaced 
with DME-LH alone (LH) or 
with DME-LH supplemented 
with  100  ng/ml  TPA  (TPA), 
or  30  #g/ml  DESPARC 
(SPARC). After incubation of 
cells for 2, 6, 10, or 24 h, the 
proteins were biosynthetically 
labeled by incubating cultures 
with [35S]methionine, and the 
total  secreted  proteins  were 
concentrated and analyzed by 
SDS-PAGE  and  autoradiog- 
raphy. The bands representing 
procollagenase  are  indicated 
at the right. The novel SPARC- 
induced proteins are indicated 
by asterisks. Molecular weight 
(xl0  -3)  markers  are  indi- 
cated.  Data  shown are  from 
one experiment;  however, the 
same results were obtained in 
a duplicate experiment. 
secondary to the action of a  SPARC-induced molecule, we 
plated three sets of parallel cultures of RSF in wells coated 
with collagen type I, with or without 30 #g/ml pure SPARC 
or DESPARC (Fig. 9 A). One set of cultures was incubated 
with pure SPARC or DESPARC for 24 h. Another set of cul- 
tures  was  incubated  with  or  without  pure  SPARC  or 
DESPARC for 7 h, the medium was removed and saved, and 
the cultures were incubated further in DME-LH for  17 h. 
From the medium that was removed and saved, we depleted 
the residual SPARC by incubation of the CM with goat anti- 
SPARC IgG bound to protein G beads; we incubated a third 
set of cultures, plated on collagen type I, with this SPARC- 
depleted CM for 15 h. To confirm that SPARC, and not a con- 
taminating  molecule in  the  preparation  of DESPARC,  in- 
duced  the  expression of collagenase,  we removed SPARC 
from a  duplicate  sample of SPARC-supplemented culture 
medium by preadsorption with goat anti-SPARC IgG-loaded 
protein G beads before the addition of this medium to cul- 
tures. To ensure that SPARC was depleted from the samples 
incubated with anti-SPARC IgG beads, we subjected dupli- 
cate  samples of SPARC,  or  CM  harvested  from SPARC- 
treated or control cultures, before and after incubation with 
anti-SPARC  IgG,  to  analysis  by  SDS-PAGE  under  non- 
denaturing conditions.  No residual SPARC was detected in 
the  SPARC-depleted  CM  by  immunoblotting  (data  not 
shown). To eliminate the possibility that serum-derived fac- 
tors associated with the washed IgG-loaded protein G beads 
may induce collagenase expression, we also incubated cul- 
tures for 24 h with medium that had been preabsorbed with 
protein G beads loaded with IgG from normal goat serum. 
All cultures were incubated with [35S]methionine  24 h after 
initial plating, and the biosynthetically labeled secreted col- 
lagenase was analyzed by immunoprecipitation.  These ex- 
periments were performed with both DESPARC  and pure 
SPARC. The data represent an average of three experiments. 
We saw a  3.5-fold increase in collagenase expression in 
cultures incubated with SPARC for 24 h (Fig. 9 B). In cul- 
tures incubated with SPARC for only 7  h,  collagenase ex- 
pression remained at basal levels, similar to that of untreated 
controls.  Interestingly,  we  saw a  2.5-fold  increase in  col- 
lagenase  expression  in  cells  incubated  with  the  SPARC- 
depleted CM harvested from cultures treated with SPARC 
for 7 h, whereas cells cultured in SPARC-depleted CM har- 
vested from untreated cells synthesized basal levels of col- 
lagenase.  Cells  that  were  incubated  with  medium  from 
which SPARC was preadsorbed before incubation,  or cells 
incubated with medium that was preincubated with protein 
G beads containing normal goat serum IgG, also synthesized 
basal levels of collagenase.  These results indicate that the 
mechanism of regulation of collagenase by SPARC is differ- 
ent from that of TPA or fibronectin fragments. The increased 
expression  of  collagenase  associated  with  SPARC  may, 
therefore, be mediated in part through a secreted factor that 
is produced during the first 7  h  of treatment with SPARC. 
The upregulation of collagenase expression in response to 
peptide growth factors and cytokines is rapid and is initiated 
within 2-6 h of exposure to the inducing agent (Frisch and 
Werb,  1989).  If the regulation of collagenase by SPARC is 
mediated by the production of a secreted intermediate such 
as a cytokine, one prediction would be that the induction of 
collagenase  expression  in  cells  incubated  with  SPARC- 
depleted CM harvested from cells treated with SPARC for 
7 h would be faster than that seen in cultures incubated with 
SPARC.  To analyze the kinetics of induction,  we compared 
the number of cells staining positive by immunofluorescence 
for cell-associated  collagenase  from cultures  treated  with 
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Figure  9.  SPARC indirectly  induces  collagenase  ex- 
pression through a  secreted  intermediate.  (A) RSF 
were plated on wells coated with collagen type I and 
incubated  in  Fibroblast  Growth  Medium,  with  or 
without 30/zg/ml DESPARC. One set of cultures  (a) 
was incubated  for 24 h.  Experimental  controls in- 
cluded RSF plated  on type I collagen-coated wells 
in  Fibroblast  Growth  Medium  supplemented  with 
DESPARC that had been preincubated with protein G 
beads loaded with goat anti-SPARC IgG, or in Fibro- 
blast  Growth Medium containing protein  G  beads 
loaded with IgG from normal goat serum. In a second 
set of cultures (b), the CM was removed 7 h after plat- 
ing, and the cultures were incubated further in unsup- 
plemented Fibroblast  Growth Medium for 17 h. The 
CM that was harvested from cells  incubated  for 7 h 
in Fibroblast Growth Medium with or without SPARC 
was depleted of residual SPARC by immunoprecipita- 
tion  with  protein  G  beads  loaded  with  goat  anti- 
SPARC IgG; this SPARC-depleted medium was added 
to a third set of cultures (c) that had been plated on 
wells  coated with collagen type I, and the cultures 
were incubated  for an additional  15 h. At 24 h after 
the initiation of the experiment,  proteins were biosyn- 
thetically  labeled by incubation of cells with [35S]me- 
thionine.  The radiolabeled  secreted collagenase was 
immunoprecipitated with anti-collagenase  mAbs, and 
analyzed by SDS-PAGE followed by autoradiography. 
(B)  The autoradiograms of the RSF treated as de- 
scribed in A from three independent experiments were 
quantified by densitometry.  The data are expressed  as 
-fold induction.  Plus and minus signs indicate  treat- 
ment with or without SPARC. 
SPARC for 35  h,  or with  SPARC-depleted CM  harvested 
from SPARC-treated cultures for 10 or 35 h (counting about 
500 cells in 4-5 microscopic fields).  We then studied RSF 
plated  on  collagen-coated  coverslips  and  treated  with 
SPARC-depleted CM from cultures incubated in serum-free 
medium with or without 30 #g/ml pure SPARC for 6.5 h at 
10 and 35 h of treatment.  RSF treated with SPARC for 10 h 
showed little induction of collagenase (see Fig. 7). However, 
at 10 h we saw a twofold increase in the total secreted col- 
lagenase and a  3.5-fold increase in the collagenase-positive 
cells in the cultures treated with CM from SPARC-treated 
cultures,  whereas  there  was  no  change  in  secreted  col- 
lagenase from cells treated with control CM.  The increase 
in collagenase-positive cells compared with the increase in 
secreted  collagenase reflects  the  short time elapsed to ac- 
cumulate  induced  collagenase  during  the  10  h  of culture 
time. By 35 h, the cells incubated with SPARC continuously 
showed a 4.3-fold increase in secreted collagenase and a 3.0- 
fold increase in collagenase-positive cells, which was similar 
to the fourfold increase in secreted collagenase and 2.7-fold 
increase in collagenase-positive cells seen in cultures treated 
with 6.5 h CM from SPARC-treated cells, compared with un- 
treated controls or cells treated with CM from control cul- 
tures.  The increase in collagenase-positive cells in cultures 
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SPARC-conditioned  medium  for  10  and  35  h  was  sig- 
nificantly different from control cultures at all time points (p 
<  0.05, Student-Newman-Kuels test).  The increase in the 
collagenase-positive cells in cultures treated for 10 h with 
SPARC-depleted CM from SPARC-treated cultures was not 
significantly  different  from  cultures  treated  with  pure 
SPARC for 35 h. Taken together, these data support the con- 
cept that a SPARC-induced secreted intermediate is at least 
a part of  the cascade by which SPARC induces the expression 
of collagenase in RSE 
Discussion 
The decision not to adhere to a substrate has developmental 
and biological consequences. This concept has been derived 
from studies on neurite outgrowth and patterning of the ner- 
vous  system (Tomaselli et al.,  1987; Dodd et al.,  1988; 
Klambt et  al.,  1991; Bovolenta and  Dodd,  1991), from 
studies of the complex adhesive interactions of cells in the 
immune system (Kieffer and Phillips, 1990;  Butcher, 1991) 
and from characterization of the migration of embryonic cell 
populations (Riou et al., 1990; ffrench-Constant  et al., 1991; 
Hynes and Lander, 1992). One proposed mechanism for di- 
minishing the adhesion of  cells to the ECM is through ECM- 
associated molecules with anti-adhesive properties (for re- 
view  see  Chiquet-Ehrismann,  1991; Sage and Bornstein, 
1991). A number of structurally dissimilar molecules with 
anti-adhesive properties  that modulate ceI1-ECM  interac- 
tions have been described: SPARC, tenascin, thrombospon- 
din, dermatan sulfate proteoglycans, and scatter factor have 
defined anti-adhesive effects on cells in culture (for review 
see Chiquet-Ehrismann,  1991; Sage and Bornstein,  1991). 
The expression of these proteins is tightly regulated to pro- 
duce developmental patterns and to respond to tissue injury; 
moreover, they localize to regions of tissue where cell divi- 
sion, migration, and ECM remodeling are prevalent (for re- 
view  see  Chiquet-Ehrismann,  1991; Sage and Bornstein, 
1991). 
In this report we have presented evidence that one of these 
anti-adhesive, ECM-associated molecules, SPARC, at a con- 
centration of '~0.5 nM, which is within physiological levels 
(Maillard et al., 1992),  initiates a cascade of events that re- 
sult in  the  increased expression of the  ECM-remodeling 
metalloproteinases. SPARC induced the expression of col- 
lagenase,  stomelysin,  and  92-kD  gelatinase,  metallopro- 
teinases capable of  degrading both basement membranes and 
interstitial  connective  tissue  matrices.  Collagenase  spe- 
cifically cleaves native, fibrillar collagens, whereas the 92- 
kD gelatinase degrades type IV collagen and denatured col- 
lagen.  Stromelysin can  degrade  many  molecules  in  the 
ECM, including proteoglycans and fibronectin (for review 
see Alexander and Werb,  1991). These results suggest that 
SPARC, in addition to its characterized effects on cell shape, 
may alter the nature of the ECM presented to the cell. 
Cellular responses  to  growth factors have traditionally 
been divided by temporal parameters into immediate, inter- 
mediate, and delayed effects. Likewise, cells can respond to 
SPARC within minutes of treatment, but there are also down- 
stream effects that can be measured hours to days after ex- 
posure. Immediate responses include actin disassembly and 
accumulation of mRNA coding for plasminogen activator 
inhibitor-1  in bovine aortic endothelial cells (Hasselaar et 
al.,  1991). Intermediate responses  include a  delay in the 
Go/S transition in  cycling bovine  aortic  endothelial cells 
(Funk and Sage, 1991). The generation ofa SPARC-induced 
secreted molecule that regulates collagenase expression in 
synovial  fibroblasts  is  another  intermediate  response  to 
SPARC, whereas a delayed response, the induction of metal- 
loproteinases in cells treated with SPARC,  occurs over a 
period of days. 
When  we  further  characterized  the  regulation  of col- 
lagenase in RSF, we noted that the regulation of collagenase 
by SPARC was distinct from the regulation of collagenase 
conferred by TPA or ligands acting through the fibronectin 
receptor.  Collagenase expression induced by SPARC pro- 
ceeded with kinetics similar to that conferred by treatments 
that act by a shape-dependent mechanism, such as culture on 
polyhydroxyethyl  methacrylate, in retracted collagen gels, or 
with cytochalasins. However, there are several reasons why 
it  is  unlikely that  SPARC  acts  solely  through  a  shape- 
dependent mechanism: (a) In contrast to the marked changes 
in the morphology of bovine nuchal fibroblasts or aortic en- 
dothelial cells mediated by SPARC (Sage et al., 1989c), RSF 
in culture remained well spread, although we may not have 
detected the subtle, transient alterations in the cytoskeleton 
that were described by Murphy-Ullrich et al. (1991); (b) we 
detected the synthesis of several novel SPARC-induced pro- 
teins that were secreted transiently before collagenase ex- 
pression; (c) supernatants that were removed from SPARC- 
treated cultures and depleted of SPARC induced coUagenase 
expression  in untreated fibroblasts,  whereas cultures from 
which SPARC was removed after 7 h of incubation did not, 
after further incubation, increase their expression of col- 
lagenase; furthermore, (d) the increase in cells staining for 
collagenase in cultures incubated with this SPARC-depleted, 
SPARC-conditioned medium for only 10 h was the same as 
that  seen  in  cultures  incubated  continuously  with  pure 
SPARC for 35 h. 
Thus, one important feature of  this induction is the synthe- 
sis or secretion of an intermediary molecule. The nature of 
this secreted intermediate is not known at present. In prelim- 
inary experiments in which we used RT-PCR  to measure 
cytokines expressed by RSF after incubation with SPARC for 
7 h, we have observed increases in mRNA for basic FGF and 
tumor necrosis factor-or and a decrease in mRNA for TGF-B 
(unpublished observations). It is known that tumor necrosis 
factor-ix  and basic FGF upregulate the expression of col- 
lagenase in cultured fibroblasts (for review see Frisch and 
Werb, 1989). Because TGF-/~ both inhibits the expression of 
metalloproteinases and induces the expression of the tissue 
inhibitor of metalloproteinases, further studies to character- 
ize this secreted intermediate will prove interesting. 
There are other examples of autocrine regulation of col- 
lagenase expression in  fibroblasts.  The  induction of col- 
lagenase by ultraviolet irradiation of fibroblasts also pro- 
ceeds through an uncharacterized, secreted intermediate (for 
review see Herrlich et al., 1992).  In synovial ceils both se- 
rum  amyloid alpha  and  B2-microglobulin,  which  are  in- 
duced in cells treated with TPA or interleukin-1  (IL-1), have 
been shown to induce the expression of collagenase in un- 
treated fibroblasts (Brinckerhoff et al.,  1989).  In other cul- 
ture systems, changes in adhesion correlate with the synthe- 
sis or secretion of growth factors (Hedin et al., 1989; Shaw 
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creased  in  response  to  a  number  of growth  factors  and 
cytokines that can be synthesized or stored in fibroblasts, in- 
cluding PDGF, basic FGF, tumor necrosis factor-tx, and IL-1 
(for review see Frisch and Werb,  1989).  It is possible that 
any of these factors may be the secreted intermediate. 
Collagenase expression is regulated in synovial fibroblasts 
by cytochalasins, by culture on a substrate with altered adhe- 
sive  properties  (polyhydroxyethyl methacrylate),  or  in 
retracted collagen gels through mechanisms that involve a 
change in the actin cytoskeleton (Aggeler et al., 1984b;  Un- 
emori and Werb, 1986),  in which cell shape is altered from 
an extended, well-spread morphology to a rounded, cuboi- 
dal morphology. There may also be a cytoskeletal compo- 
nent to the induction of collagenase in RSF treated with 
SPARC. Although these cells remained spread and adherent, 
nuchal fibroblasts and aortic endothelial cells rapidly reor- 
ganize their actin cytoskeleton and lose their focal contacts 
after exposure to SPARC (Lane and Sage, 1990).  Although 
a SPARC receptor has not yet been fully characterized, we 
cannot exclude the possibility that SPARC, acting through a 
specific  cell  surface  receptor  for  SPARC,  induces  col- 
lagenase expression in fibroblasts in vivo. 
That  SPARC  induced  collagenase  expression  in  cells 
plated on a smooth muscle matrix is consistent with the ob- 
servations of Raines et al. (1992), who noted that SPARC and 
PDGF  are  increased  in  the  neointima of atherosclerotic 
plaque. SPARC has been shown to delay the Go/S transition 
of cycling cells (Funk and Sage, 1991), to play a role in cal- 
cifying tissue (Termine et al.,  1981), and to have defined 
effects on adhesion of cells to ECM (Lane and Sage, 1990). 
SPARC binds to PDGF in such a way as to block the interac- 
tion of PDGF (AB and BB) with its receptor (Raines et al., 
1992). Although both PDGF and IL-1 induce collagenase ex- 
pression  in  synovial cells,  the  addition of PDGF  to  IL- 
l-stimulated cells diminishes the proliferation and metal- 
loproteinase expression induced by IL-1 (Kumkumian et al., 
1989). Therefore, the sequestration of PDGF by SPARC may 
have several distinct consequences, such as modifying the 
cellular response to specific cues and/or initiating a mito- 
genic or remodeling cascade in the atherosclerotic plaque. 
We have used the induction of metalloproteinase expres- 
sion in cultured cells as an assay to expand the structure- 
function analysis of the SPARC protein. Domain IV contains 
a  high-affinity Ca2+-binding site that diminishes the adhe- 
sion of  cells in culture; this domain also mediates the interac- 
tion of SPARC with immobilized collagen type I. Our work 
supports the existing evidence that this carboxyl-terminal 
Ca  2÷ binding domain is important for SPARC function. We 
anticipated that peptide 4.2, derived from SPARC sequences 
representing  the  carboxyl-terminal Ca2÷-binding  domain, 
would induce collagenase expression in RSF because this 
peptide causes  cultured fibroblasts and aortic  endothelial 
cells  to  assume a  rounder  morphology (Lane and  Sage, 
1990).  In addition, antibodies raised against peptide 4.2 re- 
act against native SPARC. Peptide 4.2 binds to collagen type 
I and blocks the interaction of native SPARC with collagen 
type I (Lane and Sage, 1990). In contrast, peptide 1.1, which 
spans sequences in the amino-terminal Ca÷-binding domain 
I of the molecule, also induces a cell shape change; however, 
peptide 1.1 did not cause significant changes in collagenase 
expression in RSE Peptide 1.1 does not inhibit SPARC bind- 
ing to immobilized collagen I (Lane and Sage, 1990).  Our 
data also suggest that the presumptive extended or-helical do- 
main is important for some functions of SPARC. We did not 
anticipate that peptide 3.2, located in a stable helical struc- 
ture of domain HI in the SPARC  molecule (Engel et al., 
1987; Bolander et al.,  1988;  Lane and Sage, 1990),  would 
regulate collagenase expression in RSF to a significant de- 
gree. It is possible that proteolytic cleavage changes the con- 
formational constraints in the  SPARC  molecule and that 
these changes in turn alter the accessibility and/or function 
of the a-helical domain. Comparison of SPARC cDNA se- 
quences  from  Xenopus and  several  mammalian  species 
shows that there is a high degree of sequence homology in 
the carboxyl-terminal domain IV and in domain III, but not 
in the  negatively charged domain I  (Damjanovski et al., 
1992).  Taken together, these data indicate that domains HI 
and IV  are  functionally important  for the  interaction of 
SPARC with ECM or ceils and for functioning of SPARC in 
vivo. 
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